Heterozygous RPA2 Variant As a Novel Genetic Cause of Telomere Biology Disorders.

Rima Kochman, Ibrahima Ba, Maïlyn Yates, Vithura Pirabakaran, Florian Gourmelon,Dmitri Churikov, Marc Laffaille,Laëtitia Kermasson, Coline Hamelin, Isabelle Marois,Frédéric Jourquin,Laura Braud, Marianne Bechara,Elodie Lainey, Hilario Nunes, Philippe Breton, Morgane Penhouet, Pierre David, Vincent Géli,Christophe Lachaud, Alexandre Maréchal, Patrick Revy,Caroline Kannengiesser, Carole Saintomé,Stéphane Coulon

Genes & development(2024)

引用 0|浏览2
暂无评分
摘要
Premature telomere shortening or telomere instability is associated with a group of rare and heterogeneous diseases collectively known as telomere biology disorders (TBDs). Here we identified two unrelated individuals with clinical manifestations of TBDs and short telomeres associated with the identical monoallelic variant c.767A>G; Y256C in RPA2 Although the replication protein A2 (RPA2) mutant did not affect ssDNA binding and G-quadruplex-unfolding properties of RPA, the mutation reduced the affinity of RPA2 with the ubiquitin ligase RFWD3 and reduced RPA ubiquitination. Using engineered knock-in cell lines, we found an accumulation of RPA at telomeres that did not trigger ATR activation but caused short and dysfunctional telomeres. Finally, both patients acquired, in a subset of blood cells, somatic genetic rescue events in either POT1 genes or TERT promoters known to counteract the accelerated telomere shortening. Collectively, our study indicates that variants in RPA2 represent a novel genetic cause of TBDs. Our results further support the fundamental role of the RPA complex in regulating telomere length and stability in humans.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要